Amphenol Other Non-Current Liabilities increased by 27.4% to $1.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.8%, from $602.10M to $1.00B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 14.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $410.20M | $408.60M | $438.70M | $454.60M | $421.20M | $436.10M | $443.30M | $464.20M | $428.30M | $433.40M | $453.70M | $464.80M | $458.10M | $489.00M | $509.40M | $602.10M | $821.50M | $894.90M | $788.50M | $1.00B |
| QoQ Change | — | -0.4% | +7.4% | +3.6% | -7.3% | +3.5% | +1.7% | +4.7% | -7.7% | +1.2% | +4.7% | +2.4% | -1.4% | +6.7% | +4.2% | +18.2% | +36.4% | +8.9% | -11.9% | +27.4% |
| YoY Change | — | — | — | — | +2.7% | +6.7% | +1.0% | +2.1% | +1.7% | -0.6% | +2.3% | +0.1% | +7.0% | +12.8% | +12.3% | +29.5% | +79.3% | +83.0% | +54.8% | +66.8% |